BackGenerate Biomedicines Overview

Generate Biomedicines Total Liabilities

Generate Biomedicines's total liabilities is $110M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$110.94M

Peer average

Loading

Generate Biomedicines Total Liabilities History

Loading

Generate Biomedicines vs. peers: Total Liabilities Comparison

Loading

Generate Biomedicines Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Generate Biomedicines (GENB) FAQ

Generate Biomedicines (GENB) currently reports a total liabilities of $110M as of March 2026. Use the charts on this page to explore Generate Biomedicines's total liabilities history and peer comparisons.

Generate Biomedicines reported $110M in total liabilities as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Generate Biomedicines, and consider following GENB for alerts when major investors trade the stock.